Juan Blaquier Awarded Inaugural FLASCO Emerging Oncology Leaders Research Grant

Research Focus

Dr. Blaquier's research focuses on gliomas, specifically exploring the mechanisms of resistance to IDH inhibitors.

Methodology

• Study of glioma cell models, particularly those with IDH mutations
• Use of real tumor samples to analyze genetic, epigenetic, and metabolic changes after IDH inhibitor treatment

Potential Implications

• Development of tailored treatment strategies to overcome glioma resistance
• Creation of new targets for personalized treatment options
• Long-term goal of developing more effective and less toxic treatments for brain tumor patients

Support

The Emerging Oncology Leaders Research Grant from the Florida Society of Clinical Oncology (FLASCO) supports Dr. Blaquier's long-term research goals by providing the opportunity to think ahead about resistance mechanisms and transform them into new treatment strategies.

Advice for Young Investigators

Dr. Blaquier advises young investigators to seek out a mentor who is both available and supportive, emphasizing the importance of mentorship in guiding their research efforts.

Resources for Young Investigators

In Florida, young investigators benefit from local societies like FLASCO, which provide resources and support for research initiatives.